GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Index / Brady / _ STN 991-210*297-B7643 AC Signs;Pack-PC; Width 210 Height 297 /Product Detail : 223856 _ STN 991-210*297-B7643 AC Signs;Pack-PC; Width 210 Height 297
Related keywords:

#223856 _ STN 991-210*297-B7643 AC Signs;Pack-PC; Width 210 Height 297

Ask technical file .

  Price : 10   EUR
12   USD
8   GBP
44   Zloty
1431   JPY
82   NOK
88   SEK
12   CHF

Product name : _ STN 991-210*297-B7643 AC Signs;Pack-PC; Width 210 Height 297

Catalog number : 223856

Quantity: 1 Pcs Per Pack

Availability: Yes

Supplier name : Brady

ask pdf gentaur products Data sheet : Ask more or other datasheet now !

Contact us about this product :

Our team will respond you as soon as possible !

Email :
Skype :
Name :
Phone :
address :
Question, Comment :
arrow security gentaurPlease retype this code below :
Brady \ ___STN_991_210*297_B7643_AC__Signs;Pack_PC;_Width_210_Height_297 \ 223856
Reload Image

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products : _ STN 991-210*297-B7643 AC Signs;Pack-PC; Width 210 Height 297


Gentaurpub

Pathways :
WP1545: miRNAs involved in DDR
WP2085: miRNAs involved in DDR

Related Genes :
[NUP210 KIAA0906 PSEC0245] Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)
[nnrE nnrD MED297_13947] Multifunctional fusion protein [Includes: ADP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.136) (ADP-dependent NAD(P)HX dehydratase); NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase)]
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[FXN FRDA X25] Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)]
[nef] Protein Nef (3'ORF) (Negative factor) (F-protein) [Cleaved into: C-terminal core protein]
[PRC1 YMR297W] Carboxypeptidase Y (CPD-Y) (cpY) (EC 3.4.16.5) (Carboxypeptidase YSCY)
[tat] Protein Tat (Transactivating regulatory protein)
[STN1 OBFC1] CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)
[TIM18 YOR297C] Mitochondrial import inner membrane translocase subunit TIM18
[hchA AC45_0622] Protein/nucleic acid deglycase HchA (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase)
[ND2 MTND2 NADH2 ndh2 HS5781_0010 HS5782_0010] NADH-ubiquinone oxidoreductase chain 2 (EC 7.1.1.2)
[pyrG MED297_13502] CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)
[dusA MED297_16794] tRNA-dihydrouridine(20/20a) synthase (EC 1.3.1.-) (EC 1.3.1.91) (U20-specific dihydrouridine synthase) (U20-specific Dus) (tRNA-dihydrouridine synthase A)
[nef] Protein Nef (3'ORF) (Negative factor) (F-protein) [Cleaved into: C-terminal core protein]
[dapB MED297_09696] 4-hydroxy-tetrahydrodipicolinate reductase (HTPA reductase) (EC 1.17.1.8)
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[nef] Protein Nef (3'ORF) (Negative factor) (F-protein) [Cleaved into: C-terminal core protein]
[cca MED297_10531] Multifunctional CCA protein [Includes: CCA-adding enzyme (EC 2.7.7.72) (tRNA-NT) (tRNA nucleotidyltransferase) (tRNA adenylyl-/cytidylyl-transferase) (tRNA CCA-pyrophosphorylase) (CCA tRNA nucleotidyltransferase); 2'-nucleotidase (EC 3.1.3.-); Phosphatase; 2',3'-cyclic phosphodiesterase (EC 3.1.4.-)]
[mutM fpg MED297_05014] Formamidopyrimidine-DNA glycosylase (Fapy-DNA glycosylase) (EC 3.2.2.23) (DNA-(apurinic or apyrimidinic site) lyase MutM) (AP lyase MutM) (EC 4.2.99.18)
[TRIP11 CEV14] Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230)
[EVPL] Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210)
[nosZ MED297_07556] Nitrous-oxide reductase (EC 1.7.2.4) (N(2)OR) (N2O reductase)
[coaX MED297_06738] Type III pantothenate kinase (EC 2.7.1.33) (PanK-III) (Pantothenic acid kinase)
[leuB MED297_17852] 3-isopropylmalate dehydrogenase (EC 1.1.1.85) (3-IPM-DH) (Beta-IPM dehydrogenase) (IMDH)
[katG MED297_07416] Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase)
[tat] Protein Tat (Transactivating regulatory protein)
[PKD1] Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein)
[nef] Protein Nef (3'ORF) (Negative factor) (F-protein) [Cleaved into: C-terminal core protein]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL1-PRO/PL2-PRO) (PL1/PL2) (Papain-like proteinases 1/2) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); Non-structural protein 11 (nsp11)]

Bibliography :
[30497197] Staged bilateral pallidotomy for dystonic camptocormia: case report.
[30449719] Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
[29739727] Topographic anatomy of the subthalamic nucleus localized by high-resolution human brain atlas superimposing digital images of cross-sectioned surfaces and histological images of microscopic sections from frozen cadaveric brains.
[29681444] High cell density suppresses BMP4-induced differentiation of human pluripotent stem cells to produce macroscopic spatial patterning in a unidirectional perfusion culture chamber.
[29654953] Effect of Subthalamic Deep Brain Stimulation on Upper Limb Dexterity in Patients with Parkinson Disease.
[29387530] Connectivity derived thalamic segmentation in deep brain stimulation for tremor.
[29113860] Dramatic psychiatric and behavioral symptoms following a subthalamic lesion.
[29098450] Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
[28982098] The Relationship of Electrophysiologic Subthalamic Nucleus Length as a Predictor of Outcomes in Deep Brain Stimulation for Parkinson Disease.
[28711737] Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease.